Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Esbjerg – page 8

103 clinical trials in Esbjerg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Esbjerg at a glance
103
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

103 trials in Esbjerg

Open in trial search

Breast cancer

Not recruiting

Study on Atorvastatin for Patients with Early Breast Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Region Midtjylland

Obesity+1

Not recruiting

Study on Testosterone Undecanoate for Muscle Strength and Mass in Men with Obesity and Low Testosterone Undergoing Bariatric Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Testosterone Undecanoate
  • Sponsor:Esbjerg Og Grindsted Sygehus

Study on Monitoring Metastatic Breast Cancer Response Using Fludeoxyglucose (18F) PET/CT for Patients with Metastatic Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Odense University Hospital

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Incontinence+1

Not recruiting

Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Mirabegron
  • Sponsor:Region Midtjylland

Diabetic nephropathy

Not recruiting

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Bayer AG

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on Heart Health in Type 2 Diabetes Patients Using Semaglutide and Dapagliflozin Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atenolol
  • Sponsor:Odense University Hospital

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Esbjerg

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Research includes evaluation of new drug combinations and therapies for reducing major cardiac events.

  • Heart Failure Prevention
  • NSTEMI Treatment Strategies
  • Cardiovascular Risk Management

Novel approaches in treating various cardiac conditions with emphasis on preventive care and therapeutic innovations.

02 Autoimmune Disorders

Clinical investigations into multiple sclerosis and inflammatory conditions, including studies of new biological therapies and treatment optimization for chronic conditions.

  • Multiple Sclerosis Treatments
  • Psoriatic Arthritis Management
  • Chronic Rhinosinusitis

Comprehensive research focusing on improving patient outcomes through targeted therapies.

03 Metabolic Health

Studies addressing obesity management and metabolic disorders, with innovative approaches to weight reduction and metabolic health improvement.

  • Weight Management Therapies
  • Diabetes Complications
  • Metabolic Disease Treatment

Advanced therapeutic strategies combining medication with lifestyle interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.